Wound Closure Hemostats – Medical Devices Pipeline Assessment, 2016

Hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective. They are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. Hemostats include active hemostats (thrombin based hemostats), and combination and passive hemostats (oxidized regenerated cellulose based hemostats, gelatin based hemostats and collagen based hemostats). GlobalData's Medical Devices sector report, “Hemostats – Medical Devices Pipeline Assessment, 2016' provides comprehensive information about the Hemostats pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Hemostats Pipeline Assessment report provides key information and data related to: Extensive coverage of the Hemostats under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates Reviews of major players involved in the pipeline product development. Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Hemostats pipeline products. Review of Recent Developments in the segment / industry The Hemostats Pipeline Assessment report enables you to: Access significant competitor information, analysis, and insights to improve your R&D strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Identify and understand important and diverse types of Hemostats under development Formulate market-entry and market expansion strategies Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline The major companies covered in the “Hemostats – Medical Devices Pipeline Assessment, 2016” report: 3-D Matrix, Ltd. Advanced Medical Solutions Group plc Anika Therapeutics, Inc. Arch Therapeutics Inc. Argon Medical Devices Inc. Baxter International Inc. Beth Israel Deaconess Medical Center, Inc. Biomedica Management Corporation Biom'Up SAS Cellphire, Inc. Covalent Medical, Inc. (Inactive) Covalon Technologies Ltd. CryoLife, Inc. Endomedix Incorporated Entegrion, Inc. Ethicon, Inc. Floralis S.A.S. Gamma Therapeutics, Inc. Haemostatix Limited Hemostasis, LLC KeraNetics, LLC LifeBond Ltd. Remedium Technologies Inc. Rice University Samyang Biopharmaceuticals Corporation Sanofi Sea Run Holdings Inc. St Teresa Medical, Inc. Suneris Technologies, Inc. The Medicines Company Therus Corporation Xcede Technologies, Inc. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type. The GlobalData Differentiation This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts. The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you comprehensive information required to drive sales, investment and deal-making activity in your business. It includes the following: 15,000+ data tables showing market size across more than 780 medical equipment segments and 15 countries, from 2007 and forecast to 2021 10,000+ primary interviews, conducted annually to ensure data and report quality 1,100+ medical equipment conference reports 2,000+ industry-leading reports per annum, covering growing sectors, market trends, investment opportunities and competitive landscape 600+ analysis reports, covering market and pipeline product analysis, by indication; medical equipment trends and issues, and investment and M&A trends 56,500+ medical equipment company profiles 4,100+ company profiles of medical equipment manufacturers in China and India 2,000+ company profiles of medical equipment manufacturers in Japan 825+ companies’ revenue splits and market shares 1,750+ quarterly and annual medical equipment company financials 700+ medical equipment company SWOTs 19,000+ pipeline product profiles 27,000+ marketed product profiles 33,000+ clinical trials 25,000+ trial investigators 20,600+ product patents 3,700+ reports on companies with products under development 21,500+ reports on deals in the medical equipment industry 1,300+ surgical and diagnostic procedures by therapy area 50+ key healthcare indicators by country For more information or to receive a free demonstration of the service, please visit: GlobalData Medical Custom Requirements Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

N/A

Reasons to buy

N/A

Companies mentioned

3-D Matrix, Ltd.

Advanced Medical Solutions Group plc

Anika Therapeutics, Inc.

Arch Therapeutics Inc.

Argon Medical Devices Inc.

Baxter International Inc.

Beth Israel Deaconess Medical Center, Inc.

Biomedica Management Corporation

Biom'Up SAS

Cellphire, Inc.

Covalent Medical, Inc. (Inactive)

Covalon Technologies Ltd.

CryoLife, Inc.

Endomedix Incorporated

Entegrion, Inc.

Ethicon, Inc.

Floralis S.A.S.

Gamma Therapeutics, Inc.

Haemostatix Limited

Hemostasis, LLC

KeraNetics, LLC

LifeBond Ltd.

Remedium Technologies Inc.

Rice University

Samyang Biopharmaceuticals Corporation

Sanofi

Sea Run Holdings Inc.

St Teresa Medical, Inc.

Suneris Technologies, Inc.

The Medicines Company

Therus Corporation

Xcede Technologies, Inc.

Table of Contents

1Table of Contents2

1.1List of Tables5

1.2List of Figures8

2Introduction9

2.1Hemostats Overview9

3Products under Development10

3.1Hemostats – Pipeline Products by Stage of Development10

3.2Hemostats – Pipeline Products by Segment11

3.3Hemostats – Pipeline Products by Territory12

3.4Hemostats – Pipeline Products by Regulatory Path13

3.5Hemostats – Pipeline Products by Estimated Approval Date14

3.6Hemostats – Ongoing Clinical Trials15

4Hemostats – Pipeline Products under Development by Companies16

4.1Hemostats Companies – Pipeline Products by Stage of Development16

4.2Hemostats – Pipeline Products by Stage of Development18

5Hemostats Companies and Product Overview20

5.13-D Matrix, Ltd. Company Overview20

5.1.13-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview20

5.2Advanced Medical Solutions Group plc Company Overview22

5.2.1Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview22

5.3Anika Therapeutics, Inc. Company Overview28

5.3.1Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview28

5.4Arch Therapeutics Inc. Company Overview30

5.4.1Arch Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview30

5.5Argon Medical Devices Inc. Company Overview34

5.5.1Argon Medical Devices Inc. Pipeline Products & Ongoing Clinical Trials Overview34

5.6Baxter International Inc. Company Overview35

5.6.1Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview35

5.7Beth Israel Deaconess Medical Center, Inc. Company Overview40

5.7.1Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview40

5.8Biomedica Management Corporation Company Overview41

5.8.1Biomedica Management Corporation Pipeline Products & Ongoing Clinical Trials Overview41

5.9Biom'Up SAS Company Overview44

5.9.1Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview44

5.10Cellphire, Inc. Company Overview46

5.10.1Cellphire, Inc. Pipeline Products & Ongoing Clinical Trials Overview46

5.11Covalent Medical, Inc. (Inactive) Company Overview48

5.11.1Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview48

5.12Covalon Technologies Ltd. Company Overview49

5.12.1Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview49

5.13CryoLife, Inc. Company Overview51

5.13.1CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview51

5.14Endomedix Incorporated Company Overview55

5.14.1Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview55

5.15Entegrion, Inc. Company Overview57

5.15.1Entegrion, Inc. Pipeline Products & Ongoing Clinical Trials Overview57

5.16Ethicon, Inc. Company Overview58

5.16.1Ethicon, Inc. Pipeline Products & Ongoing Clinical Trials Overview58

5.17Floralis S.A.S. Company Overview59

5.17.1Floralis S.A.S. Pipeline Products & Ongoing Clinical Trials Overview59

5.18Gamma Therapeutics, Inc. Company Overview61

5.18.1Gamma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview61

5.19Haemostatix Limited Company Overview62

5.19.1Haemostatix Limited Pipeline Products & Ongoing Clinical Trials Overview62

5.20Hemostasis, LLC Company Overview64

5.20.1Hemostasis, LLC Pipeline Products & Ongoing Clinical Trials Overview64

5.21KeraNetics, LLC Company Overview66

5.21.1KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview66

5.22LifeBond Ltd. Company Overview67

5.22.1LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview67

5.23Remedium Technologies Inc. Company Overview70

5.23.1Remedium Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview70

5.24Rice University Company Overview71

5.24.1Rice University Pipeline Products & Ongoing Clinical Trials Overview71

5.25Samyang Biopharmaceuticals Corporation Company Overview73

5.25.1Samyang Biopharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview73

5.26Sanofi Company Overview75

5.26.1Sanofi Pipeline Products & Ongoing Clinical Trials Overview75

5.27Sea Run Holdings Inc. Company Overview77

5.27.1Sea Run Holdings Inc. Pipeline Products & Ongoing Clinical Trials Overview77

5.28St Teresa Medical, Inc. Company Overview78

5.28.1St Teresa Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview78

5.29Suneris Technologies, Inc. Company Overview82

5.29.1Suneris Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview82

5.30The Medicines Company Company Overview83

5.30.1The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview83

5.31Therus Corporation Company Overview85

5.31.1Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview85

5.32Xcede Technologies, Inc. Company Overview86

5.32.1Xcede Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview86

6Hemostats- Recent Developments87

6.1Feb 18, 2016: Genelife Enters into Licensing Agreement with 3-D Matrix Europe87

6.2Feb 17, 2016: Z-Medica Receives Expanded CE Mark for QuikClot87

6.3Jan 21, 2016: United Health Products Announces Optimal Government Services as UHP's Exclusive Government Distributor87

6.4Dec 16, 2015: Arch Therapeutics Receives Clearance to Initiate Clinical Trial in Europe88

6.5Dec 09, 2015: Arsenal Medical Secures Funding from U.S. Army to Advance ResQFoam Trauma Product through Regulatory Approval88

6.6Dec 04, 2015: Change in B. Braun Management Board89

6.7Dec 01, 2015: Arch Therapeutics Reports Significant Wound Healing Results in Pre-Clinical Safety Study with AC5 Surgical Hemostatic Device89

6.8Nov 17, 2015: CryoLife Announces Resolution of PerClot Litigation with Medafor90

6.9Oct 28, 2015: United Health Products' HemoStyp Now Available Through Henry Schein90

6.10Oct 22, 2015: CoAg Medical And Lou Ferrigno Announce StopsBleeding Product Launch90

6.11Oct 20, 2015: Vascular Solutions Reports Third Quarter Results-201591

6.12Sep 08, 2015: Arch Therapeutics Obtains Additional Positive Safety Data for AC5 Surgical Hemostatic Device in Preclinical Toxicity Test of Sensitization93

6.13Aug 24, 2015: United Health Products Announces School Health as a Distributor94

6.14Aug 18, 2015: Dynasil Announces Xcede Technologies' Patent Application for Novel All-in-One Patch94

6.15Aug 05, 2015: LifeBond Raises USD27 Million in Series D Financing94

6.16Aug 04, 2015: Suneris CEO to Present VETIGEL at White House Demo Day94

6.17Jul 21, 2015: Vascular Solutions Reports Second Quarter Results95

6.18Jul 15, 2015: Remedium Technologies Receives FDA Clearance for Hemogrip Technology to Help Stop Bleeding97

6.19Jul 14, 2015: St. Teresa Medical Announces First Patient Enrolled in SURGICLOT Clinical Trial in U.K97

6.20Jun 26, 2015: Suneris Introduces VETIGEL as a New Wound Care Solution for Veterinarians98

6.21Jun 15, 2015: OxySure Systems Enters into Distribution Agreement with Z-Medica98

6.22Jun 09, 2015: Arch Therapeutics Obtains Additional Safety Data for Its AC5 Surgical Hemostatic Device in Successful Preclinical Toxicity Test98

6.23May 13, 2015: DuBiotech Welcomes Germany’s B.Braun99

6.24Apr 30, 2015: The Medicines Company Announces FDA Approval of RAPLIXA (Fibrin Sealant), the First and Only Powdered Fibrin Sealant Ready-to-Use for Mild to Moderate Surgical Bleeding99

6.25Apr 28, 2015: CryoLife Begins Patient Enrolment In PerClot IDE Clinical Trial100

6.26Apr 21, 2015: Vascular Solutions Reports First Quarter Results101

6.27Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study103

6.28Apr 14, 2015: Arch Therapeutics Announces Favorable Preclinical Data From an Independent Study of AC5 Surgical Hemostatic Device Versus a Popular Fibrin Sealant104

6.29Apr 07, 2015: United Health Products Announces Laboratory Test Results105

6.30Apr 01, 2015: Z-Medica Announces QuikClot Products Approved in California105

6.31Mar 27, 2015: B. Braun Group increases sales and earnings106

6.32Mar 25, 2015: Arch Therapeutics Announces Favorable Preclinical Data from an Independent Study of AC5 Surgical Hemostatic Device Versus a Popular Cellulose-Based Hemostatic Agent107

6.33Mar 23, 2015: Arch Therapeutics Announces Positive Safety Results for AC5 Surgical Hemostatic Device in Preclinical Toxicity Studies108

6.34Mar 13, 2015: Withdrawal of Application for the Approval of the Hemostat (TDM-621)108

6.35Mar 12, 2015: CryoLife Provides Update on PerClot Litigation108

7Appendix110

7.1Methodology110

7.2About GlobalData112

7.3Contact Us113

7.4Disclaimer113

List of Tables

Table 1: Hemostats – Pipeline Products by Stage of Development10

Table 2: Hemostats – Pipeline Products by Segment11

Table 3: Hemostats – Pipeline Products by Territory12

Table 4: Hemostats – Pipeline Products by Regulatory Path13

Table 5: Hemostats – Pipeline Products by Estimated Approval Date14

Table 6: Hemostats – Ongoing Clinical Trials15

Table 7: Hemostats Companies – Pipeline Products by Stage of Development16

Table 8: Hemostats – Pipeline Products by Stage of Development18

Table 9: 3-D Matrix, Ltd. Pipeline Products & Ongoing Clinical Trials Overview20

Table 14: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview22

Table 29: Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview28

Table 32: Arch Therapeutics Inc. Pipeline Products & Ongoing Clinical Trials Overview30

Table 37: Argon Medical Devices Inc. Pipeline Products & Ongoing Clinical Trials Overview34

Table 40: Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview35

Table 48: Beth Israel Deaconess Medical Center, Inc. Pipeline Products & Ongoing Clinical Trials Overview40

Table 51: Biomedica Management Corporation Pipeline Products & Ongoing Clinical Trials Overview41

Table 58: Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview44

Table 61: Cellphire, Inc. Pipeline Products & Ongoing Clinical Trials Overview46

Table 66: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview48

Table 69: Covalon Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview49

Table 74: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview51

Table 79: Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview55

Table 84: Entegrion, Inc. Pipeline Products & Ongoing Clinical Trials Overview57

Table 87: Ethicon, Inc. Pipeline Products & Ongoing Clinical Trials Overview58

Table 90: Floralis S.A.S. Pipeline Products & Ongoing Clinical Trials Overview59

Table 93: Gamma Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview61

Table 96: Haemostatix Limited Pipeline Products & Ongoing Clinical Trials Overview62

Table 101: Hemostasis, LLC Pipeline Products & Ongoing Clinical Trials Overview64

Table 106: KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview66

Table 109: LifeBond Ltd. Pipeline Products & Ongoing Clinical Trials Overview67

Table 116: Remedium Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview70

Table 119: Rice University Pipeline Products & Ongoing Clinical Trials Overview71

Table 122: Samyang Biopharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview73

Table 127: Sanofi Pipeline Products & Ongoing Clinical Trials Overview75

Table 130: Sea Run Holdings Inc. Pipeline Products & Ongoing Clinical Trials Overview77

Table 133: St Teresa Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview78

Table 140: Suneris Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview82

Table 143: The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview83

Table 146: Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview85

Table 149: Xcede Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview86

Table 152: Glossary111

List of Figures

Figure 1: Hemostats – Pipeline Products by Stage of Development10

Figure 2: Hemostats – Pipeline Products by Segment11

Figure 3: Hemostats – Pipeline Products by Territory12

Figure 4: Hemostats – Pipeline Products by Regulatory Path13

Figure 5: Hemostats – Pipeline Products by Estimated Approval Date14

Figure 6: Hemostats – Ongoing Clinical Trials15

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports